Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
To access this article, please choose from the options below
PII: S0168-8278(10)00694-X
doi:10.1016/j.jhep.2010.04.042
© 2010 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
